CompletedNCT00254462
Atomoxetine and parent training for young children with ADHD
About this title
Read the official source — NCT00254462Medication studyAges 5–6United States
Understand this study
Who was this study for?
Listed age limits: 5 years to 6 years.
- Listed locations
- Omaha and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 1, 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 93
- Sponsor
- University of Nebraska
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 5 Years to 6 Years
- Official registry ID
- NCT00254462
- Official title
Show the full official title
Pharmacological Treatment of ADHD in Young Children
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Omaha · New York · Durham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Nebraska, a university.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine and Placebo.
Who was this study for?
Listed age limits: 5 years to 6 years.
